COO Plunges 13.8% as CooperVision Inventory Woes and Weak Guidance Shatter Market Optimism

Summary
• CooperCompanies (COO) shares crater 13.81% intraday to $54.715, testing fresh 52-week lows.

• Q3 revenue of $1.07 billion missed estimates, while Q4 and full-year guidance trail analyst consensus.

• Management cites persistent U.S. channel inventory reductions at CooperVision weighing on near-term results.

• Strategic review concludes with retention of CooperSurgical and expanded $3 billion buyback authorization.
Guidance Miss and Channel Headwinds Trigger Selloff
The precipitous decline in COO is a direct response to a disappointing earnings report that failed to justify the stock's premium valuation. While adjusted EPS of $1.15 beat expectations, the top-line miss and, more critically, the forward-looking guidance drove the panic. Management explicitly stated that reduced U.S. channel inventory at CooperVision would continue to pressure results in the fourth quarter. Furthermore, the fourth-quarter EPS guidance midpoint of $1.07 fell significantly below the $1.19 consensus, and full-year EPS guidance of $4.53 missed the $4.63 estimate. This combination of current underperformance and near-term stagnation has forced a rapid repricing of the stock's future cash flows.

Technical Breakdown and High-Leverage Bearish Options Plays
The technical landscape for CooperCompanies is deteriorating rapidly, signaling a deep correction that has breached key support levels. The stock is trading well below its major moving averages, indicating a sustained bearish momentum that is unlikely to reverse without significant fundamental catalysts.

• 200-day Moving Average: $73.32 (Price is deeply below, indicating long-term downtrend)
• RSI (14): 9.87 (Extremely oversold, suggesting potential for a violent but short-lived technical bounce)
• MACD: -1.64 vs Signal -0.60 (Bearish crossover with expanding negative histogram)
• Bollinger Lower Band: $65.20 (Price has shattered the lower band, indicating extreme volatility)

Despite the oversold RSI, the structural break below the 200-day moving average and the 200D support range of $71.14–$71.65 confirms that the long-term trend is firmly bearish. The stock is currently trading at $54.715, near its 52-week low of $51.01. Given the lack of leveraged ETF data, we focus on options strategies that capitalize on the continued downside pressure or a dead-cat bounce. We have selected two options contracts that offer high leverage and strong gamma exposure, suitable for aggressive traders looking to capitalize on this volatility.

1. COO20261016P60 (Put Option)
   • Code: COO20261016P60
   • Type: Put
   • Strike: $60.00
   • Expiration: 2026-10-16
   • Key Stats: IV Ratio 53.54% (High implied volatility indicating fear), Leverage Ratio 6.75% (Moderate leverage), Delta -0.591473 (High sensitivity to price drops), Theta -0.007828 (Low time decay), Gamma 0.029873 (High price sensitivity), Turnover 9720 (Good liquidity).
   • This contract stands out because the delta of -0.59 provides substantial exposure to downside moves, while the gamma of 0.029873 ensures that the option's value accelerates rapidly as the stock falls. The turnover of 9720 indicates sufficient liquidity for entry and exit. The IV ratio of 53.54% suggests the market is pricing in significant risk, offering a premium environment for sellers, but for buyers, it reflects the urgency of the bearish sentiment.
   • Options Payoff Calculation Primer: Under a 5% downside scenario (ST = $51.98), the Call Option Payoff = max(0, 51.98 - 60) = $0. The Put Option Payoff = max(0, 60 - 51.98) = $8.02 per share.

2. COO20261120P55 (Put Option)
   • Code: COO20261120P55
   • Type: Put
   • Strike: $55.00
   • Expiration: 2026-11-20
   • Key Stats: IV Ratio 29.50% (Moderate implied volatility), Leverage Ratio 19.88% (Moderate leverage), Delta -0.462557 (Moderate sensitivity), Theta -0.000870 (Very low time decay), Gamma 0.055441 (Very high price sensitivity), Turnover 3215 (Moderate liquidity).
   • This contract is selected for its exceptional gamma of 0.055441, which is the highest among the relevant puts, making it extremely sensitive to price movements. The low theta of -0.000870 minimizes time decay risk over the near term, allowing the position to hold value even if the stock consolidates. The delta of -0.46 provides a balanced risk-reward profile for a moderate bearish view.
   • Options Payoff Calculation Primer: Under a 5% downside scenario (ST = $51.98), the Call Option Payoff = max(0, 51.98 - 55) = $0. The Put Option Payoff = max(0, 55 - 51.98) = $3.02 per share.

If $51.01 support breaks, COO20261016P60 offers accelerated short-side potential.

Short the Bounce: Watch for $51 Support Failure
The current move is driven by fundamental guidance misses rather than sector-wide rotation, making it an idiosyncratic event that requires specific risk management. The stock's proximity to its 52-week low of $51.01 is critical; a break below this level could trigger algorithmic selling and further downside. Investors should remain cautious, as the oversold RSI may invite short-term bounces, but the overarching trend remains bearish. Keep a close eye on the Medical Devices sector leader, AbbVie (ABBV), which is currently up 0.63%, highlighting that COO's weakness is isolated. Watch for a breakdown below $51.01 or a failure to hold above $55 as key signals for further shorting opportunities.